Jay Parrish Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Jay Parrish is Chief Business Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 9,260 shares of VIR, which is worth approximately $69,727. The most recent transaction as insider was on Apr 01, 2021, when has been sold 6,944 shares (Common Stock) at a price of $51.4 per share, resulting in proceeds of $356,922. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.26K
0% 3M change
0% 12M change
Total Value Held $69,727

Jay Parrish Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2021
SELL
Open market or private sale
$356,922 $51.4 p/Share
6,944 Reduced 42.85%
9,260 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$10,624 $1.53 p/Share
6,944 Added 30.0%
16,204 Common Stock
Mar 01 2021
SELL
Open market or private sale
$440,527 $63.44 p/Share
6,944 Reduced 42.85%
9,260 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$10,624 $1.53 p/Share
6,944 Added 30.0%
16,204 Common Stock
Feb 01 2021
SELL
Open market or private sale
$485,455 $69.91 p/Share
6,944 Reduced 3.03%
222,222 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
$10,624 $1.53 p/Share
6,944 Added 2.94%
229,166 Common Stock
Jan 04 2021
SELL
Open market or private sale
$182,792 $26.32 p/Share
6,945 Reduced 3.03%
222,222 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$10,348 $1.49 p/Share
6,945 Added 2.94%
229,167 Common Stock
Dec 01 2020
SELL
Open market or private sale
$218,976 $31.53 p/Share
6,945 Reduced 3.03%
222,222 Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$10,626 $1.53 p/Share
6,945 Added 2.94%
229,167 Common Stock
Nov 02 2020
SELL
Open market or private sale
$217,139 $31.27 p/Share
6,944 Reduced 3.03%
222,222 Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$10,624 $1.53 p/Share
6,944 Added 2.94%
229,166 Common Stock
Oct 01 2020
SELL
Open market or private sale
$241,339 $34.75 p/Share
6,945 Reduced 3.03%
222,222 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$10,626 $1.53 p/Share
6,945 Added 2.94%
229,167 Common Stock
JP

Jay Parrish

Chief Business Officer
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR